858414-23-0

Basic information

• Product Name: 3-(2-bromo-4-chloro-6-fluorophenyl)-5-methyl-[1,2,4]oxadiazole
• Synonyms: 3-(2-bromo-4-chloro-6-fluorophenyl)-5-methyl-[1,2,4]oxadiazole
• CAS NO: 858414-23-0
• Molecular Weight: 291.507
• Mol File: 858414-23-0.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 3-(2-bromo-4-chloro-6-fluorophenyl)-5-methyl-[1,2,4]oxadiazole(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2-bromo-4-chloro-6-fluorophenyl)-5-methyl-[1,2,4]oxadiazole(858414-23-0)
• EPA Substance Registry System: 3-(2-bromo-4-chloro-6-fluorophenyl)-5-methyl-[1,2,4]oxadiazole(858414-23-0)

Safety Data

• Hazardous Substances Data: 858414-23-0(Hazardous Substances Data)

Upstream product

• 1200120-67-7 C₇H₃BrCl₂FNO 
• 1135531-74-6 1-(2-bromo-4-chloro-6-fluorophenyl)-N-hydroxymethanimine 
• 18871-66-4 N,N-dimethylacetamide dimethyl acetal 
• 858414-24-1 2-bromo-4-chloro-6-fluoro-N-hydroxy-benzamidine 
• 208186-78-1 1,2-dibromo-5-chloro-3-fluorobenzene 
• 1135531-73-5 2-bromo-4-chloro-6-fluorobenzaldehyde 
• 858414-24-1 2-bromo-4-chloro-6-fluoro-N-hydroxybenzamidine 

Downstream Products

• 858414-26-3 tert-butyl ((1R)-1-{5-[5-chloro-3-fluoro-2-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-3-fluoropyridin-2-yl}ethyl)carbamate 
• 1135531-76-8 N-[(1R)-1-{5-[5-chloro-3-fluoro-2-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-3-fluoropyridin-2-yl}ethyl]acetamide 
• 1048969-34-1 C₂₀H₁₉ClF₂N₄O₃ 
• 1135531-77-9 (1R)-1-{5-[5-chloro-3-fluoro-2-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-3-fluoropyridin-2-yl}ethanamide 
• 1384171-39-4 [3-((R)-1-{5-[5-chloro-3-fluoro-2-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-3-fluoro-pyridin-2-yl}-ethylcarbamoyl)-oxetan-3-yl]-carbamic acid 9H-fluoren-9-ylmethyl ester 
• 1384170-93-7 3-(3-fluoro-5-(trifluoromethyl)-benzoylamino)-oxetane-3-yl-carboxylic acid ((R)-1-{5-[5-chloro-3-fluoro-2-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-3-fluoro-pyridin-2-yl}-ethyl)-amide 
• 1384170-94-8 3-(2,2,2-trifluoro-acetylamino)-oxetane-3-carboxylic acid ((R)-1-{5-[5-chloro-3-fluoro-2-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-3-fluoro-pyridin-2-yl}-ethyl)-amide 
• 1384171-37-2 3-amino-oxetane-3-carboxylic acid ((R)-1-{5-[5-chloro-3-fluoro-2-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-3-fluoro-pyridin-2-yl}-ethyl)-amide 
• 1392073-22-1 1-(2,2,2-trifluoroacetylamino)cyclopropanecarboxylic acid {(rac)-3-[5-chloro-3-fluoro-2-(5-methyl-[1,2,4]oxadiazol-3-yl)phenyl]-6,7-dihydro-5H-[1]pyrindin-7-yl}amide 

Relevant articles and documents

NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES

The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, A1, A2 and n are as described herein, compositions including the compounds and methods of using the compounds.

NEW BIARYL AMIDE DERIVATIVES

The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and A are as described herein, compositions including the compounds and methods of using the compounds.

Process development of a potent bradykinin 1 antagonist

As part of Merck's continued research effort on inflammation and pain, a safe synthesis of an orally bioavailable and CNS penetrant bradykinin 1 antagonist was developed and demonstrated on kilogram scale. The key step included a novel regioselective meta